TE_38971

Basic information Differential Expression Stage analysis Survival analysis Correlation analysis

TE family LTR9B
TE superfamily ERV1
TE class LTR
Gene -
Class Intergenic
Coding Non-coding
Tumor-specific score 3.38
Counts of samples TCGA_tumor:2; TCGA_normal:0; GTEx:0
TSS chrY(-):18690308



Transcript isoforms

Transcript_ID Gene Class Coding ORF Position
teRNA_38971.1 - Intergenic Non-coding Non-coding chrY(-):18683091,18683111,18684231,18684325,18690081,18690309
teRNA_38971.2 - Intergenic Non-coding Non-coding chrY(-):18682780,18682800,18682938,18683111,18684231,18684325,18690081,18690309
teRNA_38971.3 - Intergenic Non-coding Non-coding chrY(-):18683091,18683111,18684231,18684325,18690061,18690309
teRNA_38971.4 - Intergenic Non-coding Non-coding chrY(-):18681516,18681536,18682938,18683111,18684231,18684325,18690061,18690309


GTEx

The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.




TCGA

The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).




GTEx

The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.




TCGA

The expression of TE-initiated transcript across 33 cancer types from The Cancer Genome Atlas (TCGA).